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Background: Functional mobility (FM) is the person’s ability to move to accomplish daily
living tasks and activities. FM limitations are common in Parkinson’s disease, increase
with disease progression, and can be highly disabling. Although several studies in
Parkinson’s disease (PD) field use this concept, only recently, a formal definition has
been proposed.
Objective: We aimed to explore patient’s and health professional’s perspectives of FM
in PD.
Methods: A focus group methodology has been used. Four focus groups, with a total
of 10 patients and 10 health professionals, were performed. Six patients were early
stage and four advanced stage. The health professional’s group was composed of five
neurologists and five physiotherapists. The suitability of the new concept, the impact of
FM limitations in PD patient’s daily routine, and the potential benefit of walking aids have
been discussed.
Results: All participants were able to provide a spontaneous definition of FM, matching
with the proposed concept. All agreed that PD affects patient’s FM, increasing the
limitations with disease progression, and with the existence of a serious prejudice with
walking aids that hinders its use. Early-stage patient’s perspective seems to be more
in line with neurologist’s perspective, while the views of advanced-stage patients were
closer to physiotherapist’s views.
Conclusion: FM concept was considered as intuitive and useful. FM limitations have
an important physical and social impact in the advanced stage of the disease. Although
patients and health professionals acknowledge walking aid’s benefit improving patient’s
FM, the prejudice associated with this type of tools limits its recommendation and use.
Keywords: functional mobility, Parkinson’s disease, focus groups, concept, walking aids
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INTRODUCTION
Parkinson’s disease (PD) is a complex and fluctuating
neurodegenerative disorder associated with the presence of
motor and non-motor symptoms, which can be very disabling
and highly affect patients’ quality of life (1). Despite an optimal
disease management, many of these symptoms improve only
partially and aggravate with disease progression, resulting in
recurrent falls, reduced mobility, and loss of independence (1–3).
Functional mobility (FM) is the capacity of people to move
from one place to another, in order to participate in the activities
of daily living (ADL) at home, work, and in the community. This
concept includes movements like standing, bending, walking,
and climbing and contributes greatly to the subject’s health-
related quality of life (4).
In PD, both motor and non-motor symptoms contribute to
the appearance of FM limitations. Although poorly defined, this
concept has been frequently used in PD research. Recently, due
to its frequent misuse, there is a need to clarify and to establish a
formal concept of FM to be applied to PD (5).
The present study aims to explore, through a focus group
methodology, PD patients and health professional’s perspective
on the proposed concept of FM, exploring also the impact of FM
limitations in patient’s daily life and the strategies to deal with it.
We hope to clarify the suitability of the new concept of FM in PD
and to promote a more holistic and functional approach to the
patient’s needs.
METHODS
Study Design and Patient’s Recruitment
A focus group methodology was used. Four focus groups were
undertaken, two with patients (early and advanced disease
stage) and two with health professionals (physiotherapist and
neurologist—movement disorders specialists). Patients were
included if they had the following: (1) PD diagnosis, according
to the Movement Disorders Society clinical diagnostic criteria;
(2) a Hoehn Yahr (HY) stage between I and IV under
dopaminergic medication (MED ON); (3) the ability to
communicate with the investigator and to understand and
comply with the requirements of the study; and (4) the ability
to provide written informed consent to participate in the study.
Patients were excluded if they have been diagnosed with an
atypical parkinsonism.
Health professionals were included if they work regularly with
the PD population for at least 1 year. Participants were recruited
from CNS—Campus Neurológico, a specialized movement
disorders center (Torres Vedras, Portugal), and from the Deep
Brain Stimulation surgery waiting list of theMovement Disorders
outpatient clinic of a tertiary university hospital (Hospital Santa
Maria, Lisbon, Portugal). The CNS Local Ethical Committee
approved the study (Ref. 04-2018) and all participants provided
written informed consent.
Focus Groups
All participants that fulfilled the inclusion criteria were invited
to participate. Information about the objectives, duration,
procedures, and voluntariness was provided and the informed
consent was obtained. Demographic and clinical data were
collected for each PD patient. Patients were assessed in “ON”
state medication. To define early and advanced PD, the presence
ofmotor complications with impact in patient’s daily life, assessed
through MDS-UPDRS part IV, was used.
The focus groups followed a semi-structured script, including
questions concerning patients and health professional’s thoughts
on the concept of FM, the impact and strategies to deal with
FM limitations in daily life, and on the role of walking aids
(Appendix 1).
Each focus group took up to 90min (75min to focus group
questions and 15min to close). At the beginning of each
interview, participants were reminded of the purpose of the study
and guaranteed confidentiality. Participants were encouraged to
interact with each other, with the author intervening solely to
keep the discussion on the topic and to encourage the more
reserved members of the group to speak.
The focus group was recorded, with the agreement of
all participants.
Data Analysis
The audio recordings were transcribed and read until it reached
an overall understanding.
Transcripts of the focus groups were divided into meaningful
categories and themes. In a second step, a thorough read of the
data was performed to ensure the identified themes were evident
and a true reflection of the data was captured. Researchers moved
back and forth in a reflexive process until consensus was reached.
Descriptive statistics were used for demographic, clinical, and
therapeutic data.
RESULTS
Twenty participants were included in the study: six early-stage
patients, four advanced-stage patients, five physiotherapists, and
five neurologists. The mean age of patients was 68.0 ± 9.9 years
(71.7 ± 9.0 in early stage and 60.7 ± 8.3 in advanced stage),
with a mean disease duration of 8 ± 5.2 years (7.0 ± 6.1 in early
stage and 10.0 ± 3.0 in advanced stage) and a mean Hoehn and
Yahr score of 2.2 ± 0.4 (2.0 ± 0.4 in early stage and 2.5 ± 0.6 in
advanced stage) (Table 1).
Patients in the early-stage group were autonomous, with
an active lifestyle and/or exercise maintained through their
professional job. Patients in the advanced-stage group were
almost all retired, had less autonomy, and need more family
support. For those who were employed, working conditions have
been adapted to their specific needs.
Health professionals’ experience with PD varied between 1
and 5 years in the physiotherapist group and between 5 and 20
years in the neurologist group. All neurologists were movement
disorders specialists and all the physiotherapists worked in a
specialized movement disorders center.
The Concept of Functional Mobility
All groups were able to present a spontaneous definition of
FM that matches with the one used by the authors. All
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TABLE 1 | Demographic and clinical data.
All patients (n = 10) Early-stage group (n = 6) Late-stage group (n = 4)
Gender, M/F 7/3 3/1 4/2
Age at onset, mean years (SD) 68 ± 9.9 71.7 ± 9.0 60.7 ± 8.3
Disease duration, mean years (SD) 8 ± 5.2 7.0 ± 6.1 10.0 ± 3.0
% Tremor as first symptom 60% 50% 66.7%
MDS-UPDRS Part II, mean (SD) 12.4 ± 8.1 8.0 ± 2.3 21.43 ± 8.5
MDS-UPDRS Total score, mean (SD) 62.4 ± 23.6 61.0 ± 26.8 90.7 ± 18.3
HY, mean (SD) 2.2 ± 0.4 2.0 ± 0.0 2.5 ± 0.6
TABLE 2 | Key aspects mentioned by the four groups about the concept of FM.
What does the concept of functional mobility suggest?
Early-stage patients Late-stage patients
• Ability to move
• What we do in daily life
• Easy performing tasks
• The functionality of my mobility is
impaired
• Something that never worried me
• Autonomy in daily life
• Not needing others
• It’s getting out on the street
without anyone noticing that I have
Parkinson’s
• Wanting to do and look like you
don’t know how
• Its dressing and move in bed
Physiotherapist Neurologists




• Different degrees of limitation
• Ease to displacement
• Move to a goal
• Movement to perform a task
• Autonomy
• Related with the WHO concept of
Disability. The opposite
of impairment.
agree that FM reflects the difficulties of PD patients in daily
life (Table 2, Appendix 1).
Early-Stage Group
Early-stage PD patients associate the concept of FM with the
ability to move and with easy performance of daily life tasks. For
this group of patients, FM is something that will not worry them
in their actual state.
Advanced-Stage Group
Advanced-stage PD patients associate FM with autonomy in
daily life and with not being noticed by others in a public
environment. Dressing and turning in bed were mentioned as
activities related to FM.
Physiotherapist Group
Physiotherapists described FM as the movement for a function or
the ability to accomplish the daily tasks important for the subject,
even with limitations.
Neurologist Group
Neurologists described FM as the movement needed to perform
a task regardless of how you do it and also as something that
includes purposed displacements and transfers. For them, the
concept of FM is close to theWorld Health Organization (WHO)
concept of disability, as opposed to impairment, and should not
be limited by the existence of displacement. In their opinion, the
key aspect is the intention to accomplish a task or achieve a goal.
Neurologists highlighted the importance of having an
operationalized concept of FM. In their opinion, this outcome
may express better patient’s perception of their overall health
status and may help to adopt a more patient-centered approach.
They also suggested FM as a potential useful outcome for the
rehabilitation field.
The Impact of FM Limitations in Patient’s
Lives
Early-Stage Group
Early-stage PD patients mentioned having more difficulty in
some specific tasks (e.g., going down the stairs), mainly the need
more for time to complete their usual tasks. In their opinion,
except for direct family members and close friends, their FM
limitations were not noticed by others. This group was not able to
identify the best therapeutic strategy to deal with FM limitations.
They hypothesize that exercise may be one of them, based on
their experience of its benefits (Table 3, Appendix 1).
Advanced-Stage Group
Advanced-stage PD patients acknowledge to have limitations
in FM and consider them the main limiting factor of daily
activities, especially in “OFF” periods of medication. They refer
that this type of limitation frequently draws other’s attention to
them, making them feel ashamed. Patients try to avoid these
situations through social isolation or finding strategies to mask
the signs of the disease. According to their perspective, family
and closest friends are usually supportive, while friends and
colleagues have more difficulties understanding the fluctuations
of the disease. This usually contributes to social isolation and a
higher burden to the family members. Medication adjustments,
based on patient’s priorities, and the use of walking aids were
spontaneously referred as strategies to overcome daily life
difficulties related to FM.
Physiotherapists
Physiotherapists associated the onset of FM limitations with
disease progression. According to their experience, the first FM
limitations, mentioned to or noticed by the physiotherapist, are
getting up from a chair and getting out of bed or from the car. In
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TABLE 3 | Key aspects mentioned by the four groups about the impact of FM limitations on the patient’s life.
What is the impact of FM limitations on the patient’s daily life?
Early-stage patients Late-stage patients
• A higher difficulty to perform some tasks but mainly a slower rhythm
• Friends and distant family are unaware
• Close family refers a slowdown, difficulties in tasks like buttoning
• Exercise, cognitive training are efficacious strategies to deal with FM limitations
• Clear perception of FM limitations associated with the disease
• The most limiting factor of activities of daily living
• The “OFF” periods are the worst moments of the day
• Look for strategies to minimize the symptoms of the disease
• Feel ashamed for drawing others’ attention
Physiotherapists Neurologists
• First limitations: stand up from a chair, get out of the bed or from the car
• Associated with the stage of the disease
• Initial devaluation, followed by sadness and frustration
• In physiotherapy sessions patients learn how to deal with the limitations.
Some patients find their own strategies.
• Vary from patient to patient, according lifestyle and tolerance with himself
• Patients develop their strategies to overcome limitations until the moment they
stop working
• Sometimes the perspective of the impact of limitations and treatment goals
between a patient and a neurologist does not coincide. The perspective
between patient and caregiver is also different.
physiotherapist’s perception, patients start by devaluating these
limitations, progressing to a feeling of sadness and frustration.
The importance of physiotherapy sessions to maintain PD
patient’s functionality in daily routine was highlighted, and
the importance of patient’s education and movement strategy
training to overcome FM limitations was emphasized. It was
referred that some patients have more difficulty learning due to
the feeling of frustration or due to a higher negative emotional
burden. In the physiotherapist’s perspective, the collaboration
of the psychology team is important in these cases. It was also
referred that pharmacological interventions enhance the results
of physiotherapy interventions, whereby this group supports that
the management of PD FM limitations should be a joint work of
the multidisciplinary team.
Neurologists
In neurologists’ opinion, the interference of FM limitations
depends on the patient’s characteristics, such as affected side,
expectations, and lifestyle (active, retired). Some patients, less
demanding with themselves, seem to tolerate disability better.
According to neurologists, patients usually self-manage FM
limitations until they can no longer do it. They develop their own
strategies, such as wearing button-free clothes and shoes without
laces or getting up early to be able to perform all the necessary
tasks. It was referred that these limitations and strategies are
not always noticed by the neurologist who follows them in
the consultation. Neurologists also underline that patient’s and
caregiver’s perspectives differ on this topic.
The Use of Walking Aids
Early-Stage Group
For early-stage patients, the ability to complete a task and
performing it successfully were the aspects they valued most in
their daily lives, at the expense of the time needed.
The regular use of walking aids is not considered by this group
of participants. They believe that good monitoring by specialized
professionals and easy access to information about the disease
are enough. Some mentioned to have used Nordic walk sticks to
perform exercise and found it useful. All were open and suggested
the development of technological devices that help them with
disease-related problems, such as a device that reminds them to
correct their posture. When asked about the key requirements
of walking aids, it was mentioned the need for softeners to
smooth the gait and the ability to adapt to different surfaces, to
be light, and to have handles that allow the use of hands (Table 4,
Appendix 1).
Advanced-Stage Group
None of the patients used walking aids regularly. They see it
as potentially helpful, but they try to postpone its use as much
as possible, through medication adjustments. Advanced-stage
patients have doubts about their usefulness due to the presence
of motor fluctuation (in the “ON” medication state, they do not
think the need for this kind of help), postural instability, and
upper limb problems (which in their perspective hampers its
use). Patients who have already used walking aids did it on their
initiative, without medical advice, training, or adaptation. The
occurrence of falls, the feeling of insecurity, and the resistance
to use again on medical recommendation after a bad experience
were mentioned.
Due to the lack of experience with walking aids, patients did
not feel being able to define their key characteristics.
Physiotherapists
To physiotherapists, a threat to patient’s safety (e.g., increased
postural instability or the occurrence of falls) determines the
recommendation of walking aids. According to them, this type
of help is not always well-received. Sometimes, it is perceived
as something negative, as a sign of disease progression and of
greater dependence. The fear of falling was mentioned as a factor
that facilitates its use. It was also referred that some patients start
using walking aids too early, without clinical recommendation.
Physiotherapists stressed the need to adapt walking aids to
patient characteristics and needs and the importance of a
supervised period of training. General key characteristics were
not mentioned.
Neurologists
In the neurologist’s perspective, walking aids should be
prescribed according to the patient’s clinical characteristics.
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TABLE 4 | Key aspects mentioned by the four groups about the use of walking aids.
The use of walking aids
Early-stage patients Late-stage patients
• The ability to complete a task successfully is the aspect more valuable.
The time is no longer a priority when you know you have PD.
• The use of walking aids depends on the needs of each patient. PD don’t
need this type of solutions. A good management of the disease,
prevention and education by a specialist are more appropriated.
• Patients were open to the use technological devices or Nordic sticks.
• Due to the lack of experience, patients only mentioned suggestion for
Nordic sticks. They mentioned the existence of shock absorbers to
smooth the gait, tips adapted to different types of surfaces, light and with
handles that allow to open the hands.
• Patients try to delay the use of walking aids through medication adjustments.
• The patients used walking aids, by their own initiative, to get down, get up
or when the gait was unstable. They did not have any period training. Falls
occurred.
• Due to the existence of “ON” periods in which they have acceptable functionality,
they do not consider the use of permanent walking aids.
• Patients express some reluctance to use walking aids due to the associated
social stigma.
• A bad experience with walking aids, without training or adaptation period,
creates an insecurity that conditions future uses.
Physiotherapists Neurologists
• The presence of imbalances and an increased risk of falling are the first
warning signs for the need of walking aids.
• They are usually faced in a negative way, as a sign of disease progression
and a greater level dependence.
• The fear of falling helps accepting the recommendation of a walking aid.
• The choice of a walking aids should be personalized.
• According to the patient’s clinical characteristics.
• This recommendation sometimes does not coincide with the physiotherapist’
opinion, who usually finds it too early.
• The stigma associated with walking aids influences the patient’s receptivity and
the neurologist’s decision to suggest its use.
• Patients face the recommendation as a defeat and with frustration.
Neurologists referred to approach this topic during consultations
but to leave the decision to the physiatrist or physiotherapist,
since they are more prepared to make a formal recommendation.
It was also mentioned that their opinion about the need
for this type of aids does not always coincide with the
physiotherapist’s opinion.
In neurologist’s perspective, the use of walking aids is often
seen by patients as a loss of autonomy and never as a gain in
FM, due to the stigma associated with its use. They referred
the need to approach the topic carefully and that patient’s
reactions are usually defeat, frustration, or taking offense.
Neurologists emphasize the importance of a training period.
They also recognized that the recommendation of walking aids
is sometimes hindered by their own prejudice in relation to
this type of aids. This sometimes makes them postpone its
recommendation, more than would be desirable.
Neurologists believe that the characteristics of a walking aid
should be indicated by a physiatrist or physiotherapist.
DISCUSSION
Ten patients and 10 health professionals participated in the focus
groups. All patients were assessed in “ON” state medication.
Patients in the advanced-stage group were all recruited from the
DBS surgery waiting list, whereby although younger and with a
lower score in MDS-UPDRS part III (motor score), had a more
disabled type of PD.
The Concept of Functional Mobility
Although none of the groups has provided a definition that
fits the proposed definition perfectly, the FM concept seems to
be well-understood by patients and professionals and reflects
patient’s daily life difficulties and disease progression.
Early-stage patients and neurologists seem to be more focused
in the component of mobility, whereas advanced-stage patients
and physiotherapists highlight more the component of function.
In reality, FM is a specific type of mobility that requires
displacement and the engagement in tasks and activities at home,
work, and in the community (Table 2).
In the neurologist’s opinion, the FM concept should not be
limited by the need for displacement but is defined as the ability
to do what one proposes. This idea seems to be present in other
groups since references to functional tasks like dressing, shaving,
or drinking water were frequent. However, the existence of a
displacement is a key component of the concept. FM is the ability
of a person to move and is operationalized by the assessment
of gait, balance, and transfers during the performance of a
functional task (4, 5). This requires displacement and excludes
all types of upper limb mobility. Also, this suggestion of a
broader concept of FM falls into the definition of mobility [i.e., as
“moving by changing body position or location or by transferring
from one place to another, by carrying, moving or manipulating
objects, by walking, running or climbing, and by using various
forms of transportation.” (6)], whereby its adoption would be to
give a new name to an existing and already established concept
(Tables 2, 5).
The way the different groups described the concept seems
to reflect their personal knowledge and experience on FM
limitations. While early-stage patients and neurologists
seem to see it as a minor or distant problem, advanced-
stage patients and physiotherapists face it as a current and
major problem.
Neurologists also suggest the use of FM as an outcome that
better reflects the patient’s perception and needs regarding their
overall health status. This seems to go in line with the idea
previously published that although the assessment of specific
disease-related outcomes (e.g., tremor and rigidity) is important,
evaluating functional limitations is crucial to get a better idea
of a PD patient’s disability profile (3). Future studies should
explore if and how discrepancies about the concept between
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TABLE 5 | The definition of FM and related concepts (6–8).
Functional mobility A person’s physiological ability to move independently and
safely in a variety of environments in order to accomplish
functional activities or tasks and to participate in the activities
of daily living, at home, work and in the community.
Mobility The ability to move by changing body position or location or
by transferring from one place to another, by carrying, moving
or manipulating objects, by walking, running or climbing, and
by using various forms of transportation.
Functioning The individual’s ability to execute a task or an action of daily
life activities. Refers to all body functions, activities and
participation.
Disability A physical, mental, cognitive, or developmental condition that
impairs, interferes with, or limits a person’s ability to engage in
certain tasks or actions or participate in typical daily activities
and interactions.
Independence The ability to carry out activities that support one’s own
lifestyle and to control the care given by others.
Autonomy Self-rule that is free from both controlling interference by
others and from limitations, such as inadequate
understanding, that prevent meaningful choice.
patients in different stages and health professionals affect the FM
problem management.
The Impact of FM Limitations in Patient’s
Lives
Once more, the perspective of early-stage patients seems
closer to neurologists and that of advanced-stage patients
to physiotherapists. For advanced-stage patients and
physiotherapists, with a closer experience of FM limitations,
it was easier to describe its interference in daily activities and
its social impact and to mention strategies to overcome them
(Table 6).
The awareness of having a disease and the experience of
limitations, even minor, in daily life lead patients to value more
the ability to successfully complete a task, rather than the time
needed to perform it (9, 10). This is noteworthy since one of
the main reasons for being excluded from work and community
environments is to be unable to move at an intensity and
frequency that life requires (7). This goes in line with the idea
of a previous paper on FM in PD, in which the author refers
the superiority of perceived control above velocity (7, 11). As
mentioned in the paper, the understanding of these determinants
will help health professionals to have a more patient-centered
intervention. In a time where personalized interventions are
gaining relevancy, being aware of these aspects is crucial and may
help to blur the differences between patients and neurologists
and/or caregiver’s perspectives.
It’s also relevant the social impact of the disease. Patients
feel ashamed in public environments because of tremor and
functional limitations, and little understood by friends because
of the fluctuating aspect of the disease. Neurologist mentioned
that the impact and degree of discomfort with FM limitations
vary with the level of tolerance of patients. According to a
2017 cross-sectional study (12), the stigma of the disease and
patient’s emotional well-being affect not only the patients but
TABLE 6 | The differences and similarities in the opinions of patients and health
professionals.
Shared perspectives
• FM is related to the ability to move and perform tasks in daily life
• FM is impaired in PD
• There are different degrees of limitation, associated with disease progression
• Patients look for strategies to minimize FM limitations
• Exercise, cognitive training are efficacious strategies to deal with FM limitations
• There is a stigma associated with the use of walking aids
Different perspectives
Patients Health professionals
What is the impact of FM limitations on the patient’s daily life?
• For early stage patients FM
problems are mainly a problem of
slower rhythm.
• With the disease progression there
is a clear perception of FM
limitations, being the most limiting
factor of activities of daily living
• Advance stage patients feel
ashamed for drawing
others’ attention
• First limitations: stand up from a
chair, get out of the bed or from the
car
• Patients initially devalue the FM
problems, then fell sadness and
frustration.
• Vary from patient to patient,
according to lifestyle and tolerance
with himself
The use of walking aids
• From the perspective of early stage
patients, walking aids are not
necessary for PD.
• For both early and advance
patients FM problems can be
solved with good management of
the disease, prevention and
education by a specialist
• Patients try walking aids on their
own initiative, without a previous
training period. Falls occur.
• For both early and advanced
patients, the ability to complete a
task successfully is more valuable
than the time spent with it.
• The presence of imbalances and
an increased risk of falling are the
first warning signs for the need for
walking aids.
• Patients face the recommendation
negatively. The fear of falling helps
to accept the recommendation of a
walking aid.
• The choice of walking aid should
be personalized, according to the
patient’s clinical characteristics.
Physiotherapy sessions are
important to a test and adapt
to the walking aid that best suits the
patient.
• The time spent performing a task is
also a concern.
also caregivers. In line with this, we hypothesize that a joint
work from the psychology team with physiotherapy for teaching
compensatory strategies may be useful to help patients dealing
with FM limitations and to lessen the disease burden for patients
and caregivers. It would be interesting to know in future studies
the weight of the different motor and non-motor symptoms
for PD patient’s FM problems. This may help to optimize the
management of these problems.
The Use of Walking Aids
The stigma associated with the use of walking aids hinders
its use by patients, in early and advances stage of the disease,
and interferes with neurologist’s recommendations. Although
walking aids could allow for a more active lifestyle, the fact
of being associated with disability prevent them from being
considered as something that may enhance perceived control of
their situation (7).
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It is interesting to note the openness and acceptance of
walking aids based on technological devices or in instruments
that do not have the classic appearance of walking aids (e.g.,
Nordic sticks). It is also curious that even when patients suggest
the development of technological walking aids, they do not seem
to want to use them to be faster or to have a more active lifestyle,
but to correct aspects that draws other’s attention (posture,
dyskinesias, and freezing).
Due to the size of our sample and the fact that all patients
have the same nationality, we recognize that these results were
influenced by cultural factors. We believe that the information
generated here is important to highlight the relevance and
usefulness of the concept of FM for PD management and
research. However, we recommend conducting in the future a
larger and multinational study.
CONCLUSION
Functional mobility limitations were acknowledged by early-
stage PD patients, representing an important limiting factor
of daily activities and social participation for advanced-stage
patients. The proposed concept of FM to be applied to PD
seems to be well-understood by patients and health professionals
and reflects the impact of disease progression in patient’s lives.
Although walking aids have the potential to increase patient’s
FM, they are seen as a sign of dependency; therefore, they are
not well-accepted. Future bioengineering studies should focus
on a technological solution and avoid the look of classical
walking aids. We recommend the adoption of FM as an outcome,
in clinical routine and research, as a strategy to get a better
perception of patient’s overall health status and to adopt a more
patient-centered approach.
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